Format
Sort by
Items per page

Send to

Choose Destination

Links from PubChem Compound

Items: 1 to 20 of 94

1.

Epoxyeicosatrienoic acids (EETs) form adducts with DNA in vitro.

Funk DJ, Sorg BL, Kopka K, Schmeiser HH.

Prostaglandins Other Lipid Mediat. 2016 Mar;123:63-7. doi: 10.1016/j.prostaglandins.2016.04.006. Epub 2016 May 7.

PMID:
27166927
2.

EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice.

Kandhi S, Froogh G, Qin J, Luo M, Wolin MS, Huang A, Sun D.

Am J Hypertens. 2016 May;29(5):598-604. doi: 10.1093/ajh/hpv148. Epub 2015 Aug 24.

3.

Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.

Zhu QF, Hao YH, Liu MZ, Yue J, Ni J, Yuan BF, Feng YQ.

J Chromatogr A. 2015 Sep 4;1410:154-63. doi: 10.1016/j.chroma.2015.07.100. Epub 2015 Jul 29.

PMID:
26253834
5.

Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy.

Althurwi HN, Elshenawy OH, El-Kadi AO.

J Cardiovasc Pharmacol. 2014 Feb;63(2):167-77. doi: 10.1097/FJC.0000000000000036.

PMID:
24157956
6.

CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure.

Wang X, Ni L, Yang L, Duan Q, Chen C, Edin ML, Zeldin DC, Wang DW.

Mol Pharmacol. 2014 Jan;85(1):105-15. doi: 10.1124/mol.113.087122. Epub 2013 Oct 21.

7.

Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.

Klett EL, Chen S, Edin ML, Li LO, Ilkayeva O, Zeldin DC, Newgard CB, Coleman RA.

J Biol Chem. 2013 Jul 26;288(30):21618-29. doi: 10.1074/jbc.M113.481077. Epub 2013 Jun 13.

8.

Involvement of cytochrome epoxygenase metabolites in cutaneous postocclusive hyperemia in humans.

Cracowski JL, Gaillard-Bigot F, Cracowski C, Sors C, Roustit M, Millet C.

J Appl Physiol (1985). 2013 Jan 15;114(2):245-51. doi: 10.1152/japplphysiol.01085.2012. Epub 2012 Nov 21.

9.

Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury.

Strauss KI, Gruzdev A, Zeldin DC.

Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:18-24. doi: 10.1016/j.prostaglandins.2012.07.005. Epub 2012 Aug 16.

10.

8,9-Epoxyeicosatrienoic acid inhibits antibody production of B lymphocytes in mice.

Gao Y, Feng J, Ma K, Zhou Z, Zhu Y, Xu Q, Wang X.

PLoS One. 2012;7(7):e40258. doi: 10.1371/journal.pone.0040258. Epub 2012 Jul 3.

11.

Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma.

Norton SK, Wijesinghe DS, Dellinger A, Sturgill J, Zhou Z, Barbour S, Chalfant C, Conrad DH, Kepley CL.

J Allergy Clin Immunol. 2012 Sep;130(3):761-769.e2. doi: 10.1016/j.jaci.2012.04.023. Epub 2012 Jun 2.

12.

A soluble epoxide hydrolase inhibitor--8-HUDE increases pulmonary vasoconstriction through inhibition of K(ATP) channels.

Liu Y, Zhang J, Yu L, Cao F, Rao J, Li J, Jiang C, Falck JR, Jacobs ER, Zhu D.

Pulm Pharmacol Ther. 2012 Feb;25(1):69-76. doi: 10.1016/j.pupt.2011.11.005. Epub 2011 Dec 3.

PMID:
22155000
13.

Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation.

Brenneis C, Sisignano M, Coste O, Altenrath K, Fischer MJ, Angioni C, Fleming I, Brandes RP, Reeh PW, Woolf CJ, Geisslinger G, Scholich K.

Mol Pain. 2011 Oct 4;7:78. doi: 10.1186/1744-8069-7-78.

14.

Effects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC).

Pavlov TS, Ilatovskaya DV, Levchenko V, Mattson DL, Roman RJ, Staruschenko A.

Am J Physiol Renal Physiol. 2011 Sep;301(3):F672-81. doi: 10.1152/ajprenal.00597.2010. Epub 2011 Jun 22.

15.

Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.

Jiang H, Quilley J, Doumad AB, Zhu AG, Falck JR, Hammock BD, Stier CT Jr, Carroll MA.

Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H1990-6. doi: 10.1152/ajpheart.01267.2010. Epub 2011 Mar 11.

16.

8,9-Epoxyeicosatrienoic acid analog protects pulmonary artery smooth muscle cells from apoptosis via ROCK pathway.

Ma J, Zhang L, Li S, Liu S, Ma C, Li W, Falck JR, Manthati VL, Reddy DS, Medhora M, Jacobs ER, Zhu D.

Exp Cell Res. 2010 Aug 15;316(14):2340-53. doi: 10.1016/j.yexcr.2010.05.013. Epub 2010 May 21.

17.

Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain.

Miller TM, Donnelly MK, Crago EA, Roman DM, Sherwood PR, Horowitz MB, Poloyac SM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Dec 1;877(31):3991-4000. doi: 10.1016/j.jchromb.2009.10.012. Epub 2009 Oct 14.

18.

8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier.

Sharma M, McCarthy ET, Reddy DS, Patel PK, Savin VJ, Medhora M, Falck JR.

Prostaglandins Other Lipid Mediat. 2009 Jun;89(1-2):43-51.

19.

[Promotive effects of epoxyeicosatrienoic acids (EETs) on proliferation of tumor cells].

Shen GF, Jiang JG, Fu XN, Wang DW.

Ai Zheng. 2008 Nov;27(11):1130-6. Chinese.

PMID:
19000441
20.

Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.

Moshal KS, Zeldin DC, Sithu SD, Sen U, Tyagi N, Kumar M, Hughes WM Jr, Metreveli N, Rosenberger DS, Singh M, Vacek TP, Rodriguez WE, Ayotunde A, Tyagi SC.

J Cell Physiol. 2008 Jun;215(3):771-81. doi: 10.1002/jcp.21356.

Supplemental Content

Support Center